2010 BC Guide in Determining Fitness to Drive
2010 BC Guide in Determining Fitness to Drive 2010 BC Guide in Determining Fitness to Drive
ConditionType of drivingimpairment andassessment approachPrimary functionalability affectedAssessment toolsChronic renaldisease (Stage 3and 4)End-stage renaldiseasePersistent Impairment:Functional assessmentCognitiveMay also result ingeneral debilityDriver’s MedicalExamination ReportCognitive screeningtools such as;MOCA, MMSE,SIMARD-MD,Trails A or BDriveABLEassessmentRenal transplantPersistent Impairment:Functional assessmentCognitiveDriver’s MedicalExamination ReportCognitive screeningtools such as;MOCA, MMSE,SIMARD-MD,Trails A or BDriveABLEassessment14.5 CompensationIndividuals with chronic renal disease are not able to compensate for their functional impairment.132
GUIDELINES14.6 Private and commercial drivers with stage 1 or 2 renal diseaseApplicationAssessment guidelinesFitness guidelinesOSMV determinationguidelinesConditionsRestrictionsRe-assessmentguidelinesPolicy rationaleThese guidelines apply to driver fitness determinations for privateand commercial drivers who have stage 1 or 2 chronic renal disease.If further information regarding an individual’s medical condition isrequired, OSMV will request: a Driver’s Medical Examination Report, or additional information from the treating physician.Individuals may drive.Individuals are fit to drive.No conditions are required.No restrictions are required.OSMV will not re-assess, other than routine commercial or agerelatedre-assessmentStage 1 or 2 chronic renal disease is unlikely to cause impairment ofthe functions needed for driving.133
- Page 95 and 96: 9.4 Medical condition chapter templ
- Page 97 and 98: Private and commercial drivers who
- Page 99 and 100: Chapter 11: Diabetes - Hypoglycemia
- Page 101 and 102: PercentFigure 1 - Prevalence of Dia
- Page 103 and 104: neuropathy, nephropathy, cardiovasc
- Page 105 and 106: 11.7 Private and commercial drivers
- Page 107 and 108: 11.8 Private drivers with diabetes
- Page 109 and 110: 11.9 Commercial drivers with diabet
- Page 111 and 112: RestrictionsRe-assessmentguidelines
- Page 113 and 114: Policy rationaleSevere hypoglycemia
- Page 115 and 116: 11.12 Private drivers who have pers
- Page 117 and 118: 11.13 Commercial drivers who have a
- Page 119 and 120: 11.14 Commercial drivers who have a
- Page 121 and 122: 11.15 Commercial drivers who have p
- Page 123 and 124: PART B - HYPOGLYCEMIA11a. Has the p
- Page 125 and 126: Produce my glycemic log for my doct
- Page 127 and 128: Deep-vein thrombosisDeep-vein throm
- Page 129 and 130: Aneurysms less than 5 cm in diamete
- Page 131 and 132: GUIDELINES12.6 Private and commerci
- Page 133 and 134: 12.7 Private drivers who have an an
- Page 135 and 136: 12.9 Commercial drivers who have an
- Page 137 and 138: Chapter 13: Musculoskeletal Conditi
- Page 139 and 140: ConditionType of drivingimpairment
- Page 141 and 142: GUIDELINES13.6 Private and commerci
- Page 143 and 144: ConditionsRestrictionsRe-assessment
- Page 145: 14.3 Chronic renal disease and adve
- Page 149 and 150: 14.8 Private drivers with end-stage
- Page 151 and 152: 14.10 Private and commercial driver
- Page 153 and 154: Level ofImpairmentMildlyImpairedMod
- Page 155 and 156: GUIDELINES15.6 Private and commerci
- Page 157 and 158: 15.8 Commercial drivers with modera
- Page 159 and 160: 15.10 Commercial drivers with sever
- Page 161 and 162: Policy rationaleDrivers who require
- Page 163 and 164: Chapter 16: Vestibular DisordersBAC
- Page 165 and 166: One study identified that 32.5% of
- Page 167 and 168: ConditionType ofdrivingimpairmentan
- Page 169 and 170: Re-assessmentguidelinesPolicy ratio
- Page 171 and 172: 16.8 Private and commercial drivers
- Page 173 and 174: 16.10 Private and commercial driver
- Page 175 and 176: Individuals who have undergone valv
- Page 177 and 178: Episodic impairmentThe potential ep
- Page 179 and 180: GUIDELINES17.6 Policy rationaleThes
- Page 181 and 182: 17.9 Commercial drivers with corona
- Page 183 and 184: 17.11 Private drivers who have had
- Page 185 and 186: 17.13 Private and commercial driver
- Page 187 and 188: 17.15 Private drivers who have vent
- Page 189 and 190: 17.17 Private and commercial driver
- Page 191 and 192: 17.19 Private drivers who have sust
- Page 193 and 194: 17.21 Commercial drivers who have s
- Page 195 and 196: 17.23 Private and commercial driver
ConditionType of driv<strong>in</strong>gimpairment andassessment approachPrimary functionalability affectedAssessment <strong>to</strong>olsChronic renaldisease (Stage 3and 4)End-stage renaldiseasePersistent Impairment:Functional assessmentCognitiveMay also result <strong>in</strong>general debility<strong>Drive</strong>r’s MedicalExam<strong>in</strong>ation ReportCognitive screen<strong>in</strong>g<strong>to</strong>ols such as;MOCA, MMSE,SIMARD-MD,Trails A or B<strong>Drive</strong>ABLEassessmentRenal transplantPersistent Impairment:Functional assessmentCognitive<strong>Drive</strong>r’s MedicalExam<strong>in</strong>ation ReportCognitive screen<strong>in</strong>g<strong>to</strong>ols such as;MOCA, MMSE,SIMARD-MD,Trails A or B<strong>Drive</strong>ABLEassessment14.5 CompensationIndividuals with chronic renal disease are not able <strong>to</strong> compensate for their functional impairment.132
Change language